AccurKardia has been named a finalist in the Digital Health Hub Foundation’s Digital Health & AI Awards 2026 at HLTH, in the Rising Star track’s Cardiometabolic, Obesity & Diabetes category, selected from more than 1,300 submissions. The company’s FDA-cleared software as a medical device interprets ECGs beat by beat in near real time and has been used in more than 12,000 patient studies across 12 states this year, with the aim of bringing timely, physician-ready ECG interpretation to every patient, including in the almost half of US counties that have no cardiologist.
AccurKardia named a finalist in the Digital Health Hub Foundation Digital Health & AI Awards 2026
